An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors
Recruiting
N/A
Interventional Study
Solid Tumor, Adult
Solid Tumor, Childhood
Hematologic Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 2 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 160 (estimated)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a study to explore the phenotypic and transcriptional changes of different cellular components in the tumor following the injection of somatic cell therapy drugs.
The second objective is to explore phenotypic and transcriptional changes of different cellular components in blood and bone marrow following injection of somatic cell therapy drugs.Then correlate the phenotypic and transcriptio…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient affiliated to a social security regimen
* Tumor lesion accessible to core biopsies
* Patient who is fully informed, able to comply with the protocol and who signed the informed consent
* Pediatric patients \> than 2 years old can be included
* No restriction about the …
Contacts
Cristina CASTILLA LLORENTE, MD
+33 (0)1 42 11 42 39
cristina.castilla-llorente@gustaveroussy.fr
CONTACT